2-Geranyl-1-methoxyerythrabyssin II alleviates lipid accumulation and inflammation in hepatocytes through AMPK activation and AKT inhibition

In conclusion, GMET alleviated lipid accumulation and inflammation to preserve normal hepatocyte function in steatohepatitis. Thus, GMET is a novel potential multi-targeting compound to improve steatohepatitis.PMID:37782374 | DOI:10.1007/s12272-023-01464-z
Source: Archives of Pharmacal Research - Category: Drugs & Pharmacology Authors: Source Type: research